What are typical cosentyx complications?

Cosentyx, also known as secukinumab, is a biologic medication used to treat various types of arthritis, including psoriatic arthritis and ankylosing spondylitis. While generally well-tolerated, Cosentyx has been associated with several potential complications.

Some of the more common side effects of Cosentyx include injection site reactions, such as redness, itching, or swelling [1]. In rare cases, Cosentyx may also cause more serious complications, such as an increased risk of infections, including upper respiratory tract infections, bronchitis, and pneumonia [2].

Cosentyx has also been linked to the development of inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, in some patients [3]. Additionally, there have been reports of cases of psoriasis exacerbation, including the development of psoriatic erythroderma, a rare and severe form of psoriasis [4].

According to the medication's label approved by the FDA [5], Cosentyx may also cause a range of other complications, including hypersensitivity reactions (such as anaphylaxis), lupus-like reactions (such as subacute cutaneous lupus erythematosus), and multiple sclerosis-like reactions (such as demyelination).

It's essential for patients taking Cosentyx to be closely monitored for signs of complications and to report any new or worsening symptoms to their healthcare provider promptly [6][7].

Sources:

[1] DrugPatentWatch.com www.drugpatentwatch.com - Secukinumab (COSENTYX)

[2] ClinicalTrials.gov - Secukinumab for Moderate to Severe Rheumatoid Arthritis

[3] Drugs.com - Secukinumab

[4] National Psoriasis Foundation - Side effects of psoriasis treatments

[5] www.accessdata.fda.gov

[6] www.cosentyx.com - Important Safety Information

[7] Mayo Clinic - Secukinumab